Mid-term outcome of children with latent rheumatic heart disease in eastern Nepal

Nikesh Raj Shrestha1, Dorothea Bruelisauer2, Surendra Uranw3

  • 1Department of Cardiology, Neuro Cardio and Multispeciality Hospital, Biratnagar, Nepal.

Open Heart
|April 6, 2021
PubMed

Insights

Early echocardiographic screening detects subclinical rheumatic heart disease in children. Definite rheumatic heart disease regressed in 27.8% of cases, while borderline cases showed spontaneous reversibility in less than half.

Area of Science:

  • Pediatric Cardiology
  • Rheumatic Heart Disease Epidemiology
  • Echocardiography

Background:

  • Rheumatic heart disease (RHD) is a significant global health concern, particularly in endemic regions.
  • Early detection of subclinical RHD through echocardiography is crucial for timely intervention.
  • The natural history of latent RHD in children requires further elucidation.

Purpose of the Study:

  • To prospectively investigate the course of subclinical rheumatic heart disease detected by echocardiography in children.
  • To assess disease regression, progression, and stability in definite and borderline RHD cases.
  • To identify potential predictors of disease course and adherence to secondary antibiotic prophylaxis.

Main Methods:

  • Prospective cohort study involving children with echocardiographic evidence of definite or borderline RHD based on World Heart Federation Criteria.
  • Follow-up assessments were conducted to evaluate valvular lesions and clinical status.
  • Statistical analysis, including univariate analysis, was performed to identify predictors.

Main Results:

  • Of 53 children with definite (36) or borderline (17) RHD, 44 were followed for a median of 1.9 years.
  • Definite RHD regressed in 27.8% of cases; 55.6% had stable disease.
  • Borderline RHD showed regression in 41.2%, progression in 17.6%, and stability in 23.5%.

Conclusions:

  • Definite rheumatic heart disease regressed in approximately one in four children.
  • Borderline RHD demonstrated spontaneous reversibility in less than half of cases, with progression to definite RHD in one in five.
  • No predictors for disease regression or adherence issues were identified.
Abstract

Related Concept Videos

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
197
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
100
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
157
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
107
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
90
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
70